Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecules and Cells

• Publication date

  2015-09-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molcel.2015.07.029PMID 26365377PMCID PMC4575890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice

  2015cited by this paper
• Phosphoproteomics reveals distinct modes of Mec1/ATR signaling during DNA replication.

  2015cited by this paper
• Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors

  2015cited by this paper
• ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.

  2014cited by this paper
• Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

  2014cited by this paper
• Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion.

  2014cited by this paper
• Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation

  2013cited by this paper
• RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells

  2013influential reference
• ATR phosphorylates SMARCAL1 to prevent replication fork collapse.

  2013influential reference
• DNA structure-specific priming of ATR activation by DNA-PKcs

  2013cited by this paper
• Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

  2013cited by this paper
• Epigenetic and genetic features of 24 colon cancer cell lines

  2013cited by this paper
• ATR prohibits replication catastrophe by preventing global exhaustion of RPA.

  2013influential reference
• ATR activates the S-M checkpoint during unperturbed growth to ensure sufficient replication prior to mitotic onset.

  2013cited by this paper
• Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates

  2013cited by this paper
• Causes and consequences of replication stress

  2013cited by this paper
• DNA replication timing.

  2013cited by this paper
• Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.

  2013cited by this paper
• DNA damage sensing by the ATM and ATR kinases.

  2013cited by this paper
• ATR maintains select progenitors during nervous system development

  2012cited by this paper
• Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption

  2012cited by this paper
• DNA damage‐induced CHK1 autophosphorylation at Ser296 is regulated by an intramolecular mechanism

  2012cited by this paper
• Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.

  2012cited by this paper
• Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias

  2012cited by this paper
• A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

  2012cited by this paper
• Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR.

  2012cited by this paper
• Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

  2011cited by this paper
• ATR: a master conductor of cellular responses to DNA replication stress.

  2011cited by this paper
• A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations

  2011cited by this paper
• Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.

  2011cited by this paper
• Structure-Specific DNA Endonuclease Mus81/Eme1 Generates DNA Damage Caused by Chk1 Inactivation

  2011cited by this paper
• Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors

  2011cited by this paper
• How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?

  2010cited by this paper
• The DNA damage response: making it safe to play with knives.

  2010cited by this paper
• Mec1 is one of multiple kinases that prime the Mcm2-7 helicase for phosphorylation by Cdc7.

  2010cited by this paper
• Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.

  2010cited by this paper
• Chk1 promotes replication fork progression by controlling replication initiation

  2010cited by this paper
• Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response*

  2009cited by this paper
• A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging

  2009cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress*

  2009cited by this paper
• ATR: an essential regulator of genome integrity

  2008cited by this paper
• University of Birmingham Claspin promotes normal replication fork rates in human cells

  2008cited by this paper
• Chk1 regulates the density of active replication origins during the vertebrate S phase

  2007cited by this paper
• Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss.

  2007cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• of Birmingham Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase

  2006cited by this paper
• Inhibition of Human Chk1 Causes Increased Initiation of DNA Replication, Phosphorylation of ATR Targets, and DNA Breakage

  2005cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  2005cited by this paper
• Distinct modes of ATR activation after replication stress and DNA double‐strand breaks in Caenorhabditis elegans

  2005cited by this paper
• ATR and ATM regulate the timing of DNA replication origin firing

  2004cited by this paper
• An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication.

  2003cited by this paper
• Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes

  2003cited by this paper
• SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.

  2003cited by this paper
• Phenotypic analysis of separation-of-function alleles of MEI-41, Drosophila ATM/ATR.

  2003cited by this paper
• Mouse ribonucleotide reductase R2 protein: A new target for anaphase-promoting complex-Cdh1-mediated proteolysis

  2003cited by this paper
• Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage

  2003cited by this paper
• Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.

  2003cited by this paper
• Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.

  2001cited by this paper
• ATR and ATRIP: Partners in Checkpoint Signaling

  2001cited by this paper
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• Activation of dormant origins of DNA replication in budding yeast.

  1999cited by this paper
• Telomerase activity in 144 brain tumours.

  1998cited by this paper
• A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools.

  1998cited by this paper
• Identification of RNR4, encoding a second essential small subunit of ribonucleotide reductase in Saccharomyces cerevisiae

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

  1995cited by this paper
• Fission yeast genes involved in coupling mitosis to completion of DNA replication.

  1992cited by this paper

• Targeting ATR in Cancer therapy: A drug discovery perspective.

  2026cites this paper
• Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis

  2026cites this paper
• Precise control of transcription condensates across S phase balances linker histone expression with DNA replication, ensuring genome stability.

  2026cites this paper
• Microhomology-mediated end joining acts directly on replication forks to repair single-ended double strand breaks

  2026cites this paper
• Aging-declined RNA exportation impairs hematopoietic stem cells by inducing R-loop

  2025cites this paper
• Mechanism of DNA replication fork breakage and PARP1 hyperactivation during replication catastrophe.

  2025cites this paper
• Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration

  2025cites this paper
• Targeting the crosstalk of metabolism reprogramming and replication stress: novel strategy to combat cancer

  2025cites this paper
• High tide or low tide: the transport and metabolism of mitochondrial nucleotides

  2025cites this paper
• Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer

  2025cites this paper
• ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment

  2025cites this paper
• Replication stress responses in human lymphocytes change sex-specifically during aging

  2025cites this paper
• Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage

  2025cites this paper
• Distinct ATRX functions cooperate with 9-1-1 and CST complexes to safeguard replication and telomere integrity

  2025cites this paper
• The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe

  2025cites this paper
• DNA damage response regulator ATR licenses PINK1-mediated mitophagy

  2025cites this paper
• Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferons

  2025cites this paper
• Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation

  2025cites this paper
• The single-stranded DNA–binding factor SUB1/PC4 alleviates replication stress at telomeres and is a vulnerability of ALT cancer cells

  2025cites this paper
• Inhibition of Ribonucleotide Reductase Subunit M2 Enhances the Radiosensitivity of Metastatic Pancreatic Neuroendocrine Tumor.

  2024cites this paper
• Exploiting WEE1 kinase activity as FUS::DDIT3-dependent therapeutic vulnerability in myxoid liposarcoma

  2024cites this paper
• DNA Repair and Replicative Stress Addiction in Neuroblastoma

  2024cites this paper
• The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

  2024influential citation
• A phosphorylation code coordinating transcription condensate dynamics with DNA replication

  2024cites this paper
• Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

  2024cites this paper
• Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes

  2024cites this paper
• The fork restart factor PHF6 interacts with RRM2 and binds to H3K56ac marked nascent DNA

  2024influential citation
• A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.

  2024cites this paper
• Targeting ATR in patients with cancer

  2024cites this paper
• Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

  2024cites this paper
• Understanding the interplay between dNTP metabolism and genome stability in cancer

  2024cites this paper
• Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets.

  2024cites this paper
• ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping

  2024cites this paper
• Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in Oncology

  2024cites this paper
• Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency.

  2024cites this paper
• Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1.

  2023cites this paper
• Genome maintenance meets mechanobiology

  2023cites this paper
• The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork

  2023cites this paper
• ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms

  2023cites this paper
• Advances in DNA damage response inhibitors in colorectal cancer therapy

  2023cites this paper
• Cyclers’ kinases in cell division: from molecules to cancer therapy

  2023cites this paper
• Interplay between the DNA damage response and the life cycle of DNA tumor viruses

  2023cites this paper
• ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei.

  2023cites this paper
• An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress

  2023cites this paper
• Chronic treatment with ATR and CHK1 inhibitors does not substantially increase the mutational burden of human cells.

  2023cites this paper
• DNA-Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension.

  2023cites this paper
• Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

  2023cites this paper
• ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion

  2023influential citation
• The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

  2023cites this paper
• A landscape of response to drug combinations in non-small cell lung cancer

  2023cites this paper
• The loss of DNA polymerase epsilon accessory subunits POLE3–POLE4 leads to BRCA1-independent PARP inhibitor sensitivity

  2023cites this paper
• Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe

  2023cites this paper
• Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy

  2023cites this paper
• For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus.

  2023cites this paper
• The ethanol extract of Cyperus exaltatus var. iwasakii exhibits cell cycle dysregulation, ERK1/2/p38 MAPK/AKT phosphorylation, and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo.

  2023cites this paper
• Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness

  2023cites this paper
• ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion

  2023cites this paper
• RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer

  2022cites this paper
• ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus

  2022cites this paper
• A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells

  2022cites this paper
• Profilin-1 regulates DNA replication forks in a context-dependent fashion by interacting with SNF2H and BOD1L

  2022cites this paper
• Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

  2022cites this paper
• Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

  2022influential citation
• ATR protects centromere identity by promoting DAXX association with PML nuclear bodies

  2022cites this paper
• The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment

  2022cites this paper
• RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

  2022cites this paper
• Hallmarks of DNA replication stress.

  2022cites this paper
• Mechanisms used by cancer cells to tolerate drug-induced replication stress.

  2022cites this paper
• Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment

  2022cites this paper
• A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress

  2022cites this paper
• Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer

  2022cites this paper
• Rad53 arrests leading and lagging strand DNA synthesis via distinct mechanisms in response to DNA replication stress

  2022cites this paper
• Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia

  2022cites this paper
• DNA repair defects in cancer and therapeutic opportunities

  2022influential citation
• Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations

  2022cites this paper
• Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.

  2022cites this paper
• LAP2α preserves genome integrity through assisting RPA deposition on damaged chromatin

  2022cites this paper
• A DNA damage–induced phosphorylation circuit enhances Mec1ATR Ddc2ATRIP recruitment to Replication Protein A

  2022cites this paper
• Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome.

  2022cites this paper
• Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors

  2022cites this paper
• Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors

  2022cites this paper
• Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance

  2022cites this paper
• ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery: Evidence for Modular Integration of ATM/ATR/DNA-PKcs Functions

  2022cites this paper
• Leveraging the replication stress response to optimize cancer therapy

  2022cites this paper
• Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer

  2022cites this paper
• Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

  2022cites this paper
• Borna disease virus 1 impairs DNA double-strand break repair through the ATR/Chk1 signalling pathway, resulting in learning and memory impairment in rats.

  2022cites this paper
• Hydroxyurea—The Good, the Bad and the Ugly

  2021cites this paper
• An extending ATR-CHK1 circuitry: the replication stress response and beyond.

  2021cites this paper
• A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers

  2021cites this paper
• A-type lamins are critical for the recruitment of RPA and RAD51 to stalled replication forks to maintain fork stability

  2021cites this paper
• KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance

  2021cites this paper
• Targeting the replication stress response through synthetic lethal strategies in cancer medicine.

  2021cites this paper
• ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways

  2021cites this paper
• Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53

  2021cites this paper
• Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies.

  2021cites this paper
• Fork Slowing and Reversal as an Adaptive Response to Chronic ATR Inhibition

  2021cites this paper
• Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach

  2021cites this paper
• Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer

  2021cites this paper
• A mechanism for Rad53 to couple leading- and lagging-strand DNA synthesis under replication stress in budding yeast

  2021cites this paper